Physicochemical Properties
| Molecular Formula | C17H24CLN3O2 |
| Molecular Weight | 337.848 |
| Exact Mass | 337.156 |
| CAS # | 333353-44-9 |
| Related CAS # | 333353-44-9;NBD-556 HCl; |
| PubChem CID | 1570601 |
| Appearance | Typically exists as solid at room temperature |
| LogP | 4.073 |
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 3 |
| Rotatable Bond Count | 2 |
| Heavy Atom Count | 23 |
| Complexity | 441 |
| Defined Atom Stereocenter Count | 0 |
| SMILES | O=C(C(NC1CC(C)(NC(C)(C1)C)C)=O)NC2=CC=C(C=C2)Cl |
| InChi Key | ZKXLQCIOURANAD-UHFFFAOYSA-N |
| InChi Code | InChI=1S/C17H24ClN3O2/c1-16(2)9-13(10-17(3,4)21-16)20-15(23)14(22)19-12-7-5-11(18)6-8-12/h5-8,13,21H,9-10H2,1-4H3,(H,19,22)(H,20,23) |
| Chemical Name | N'-(4-chlorophenyl)-N-(2,2,6,6-tetramethylpiperidin-4-yl)oxamide |
| Synonyms | NBD556; NBD 556; NBD-556 |
| HS Tariff Code | 2934.99.9001 |
| Storage |
Powder-20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month |
| Shipping Condition | Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs) |
Biological Activity
| ln Vitro | NBD-556 (1-100 μM) suppresses the fusion of cells and viruses mediated by the HIV-1 envelope [1]. The laboratory-adapted HIV-1 IIIB, MN, and V32 strains are inhibited from infecting MT-2 cells by NBD-556, with IC50 values of 6.5, 15.9, and 5.3 µM, respectively [1]. NBD-556 (1-100 μM) has an IC50 of 22.6 μM and suppresses CD4-dependent viruses in a dose-dependent manner [1]. |
| References |
[1]. Zhao Q, Ma L, Jiang S, Lu H, Liu S, He Y, Strick N, Neamati N, Debnath AK. Identification of N-phenyl-N'-(2,2,6,6-tetramethyl-piperidin-4-yl)-oxalamides as a new class of HIV-1 entry inhibitors that prevent gp120 binding to CD4. Virology. 2005 Sep 1;339 [2]. Schon A, et al. Thermodynamics of binding of a low-molecular-weight CD4 mimetic to HIV-1 gp120. Biochemistry. 2006 Sep 12;45(36):10973-10980. |
Solubility Data
| Solubility (In Vitro) | DMSO : ~33.33 mg/mL (~98.66 mM) |
| Solubility (In Vivo) |
Solubility in Formulation 1: ≥ 2.5 mg/mL (7.40 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 900 μL of corn oil and mix evenly.  (Please use freshly prepared in vivo formulations for optimal results.) |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 2.9599 mL | 14.7995 mL | 29.5989 mL | |
| 5 mM | 0.5920 mL | 2.9599 mL | 5.9198 mL | |
| 10 mM | 0.2960 mL | 1.4799 mL | 2.9599 mL |